EUVIMEDEUVIMED entdecken
Open Access

Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center

Nathaniel A Cohen, David Choi, Tenzin Choden, Noa Krugliak Cleveland, Russell D Cohen, David T Rubin

Clinical Gastroenterology and Hepatology · 2023-08 · 21 (9) · 2407-2409.e2

DOI: 10.1016/j.cgh.2022.03.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2023-08. Verfasst von Nathaniel A Cohen und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Chicago Inflammatory Bowel Disease Center, Chicago, Illinois. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Gilead Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon and rectum. Long-term therapy is generally required to achieve and maintain disease control.1 In May 2021 the US Food and Drug Administration approved the use of ozanimod in patients with moderate to severe UC. We describe the first report of the use of ozanimod in real-world clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeUnited StatesHumansIndansOxadiazoles

Substanzen

ozanimodIndansOxadiazoles

Autor:innen und Institutionen

  • University of Chicago Inflammatory Bowel Disease Center, Chicago, Illinois.
  • University of Chicago Inflammatory Bowel Disease Center, Chicago, Illinois. Electronic address: drubin@medicine.bsd.uchicago.edu.

Förderung

  • NIDDK NIH HHS
  • Gilead Sciences

Zitieren

APA

Cohen, N. A., Choi, D., Choden, T., Cleveland, N. K., Cohen, R. D., & Rubin, D. T. (2023). Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center. Clinical Gastroenterology and Hepatology, 21(9), 2407-2409.e2. https://doi.org/10.1016/j.cgh.2022.03.035

Vancouver

Cohen NA, Choi D, Choden T, Cleveland NK, Cohen RD, Rubin DT. Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center. Clinical Gastroenterology and Hepatology. 2023;21(9):2407-2409.e2. doi:10.1016/j.cgh.2022.03.035

BibTeX
@article{Cohen2023,
  author = {Cohen, Nathaniel A and Choi, David and Choden, Tenzin and Cleveland, Noa Krugliak and Cohen, Russell D and Rubin, David T},
  title = {Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2023},
  volume = {21},
  number = {9},
  pages = {2407--2409.e2},
  doi = {10.1016/j.cgh.2022.03.035}
}
Kostenlos starten →